RIEGER JAYSON (CEO and President) purchased 106.8% of their position (94.31K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $400.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/25/2025ACC: 0002043558-25-000003
DirectorOfficer· CEO and President
Since Nov 2024
+117.89K
Net shares
Net buyer
$400.1K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
117.89K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+94.31K
Price / share
$4.24
Trade value
$400.11K
% of position
106.8%
11/25/2025
88.28K→182.59K
Total
Net shares
+94.31K
Net value
$400.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2025 | P · Purchase | +94.31K | $4.24 | $400.11K | 106.8% | 88.28K | 182.59K |
| Total | +94.31K | $400.11K | ||||||
Derivative Transactions1
Series C Warrant (right to buy)
Direct
Converts to
Common Stock
23.58K shares
Shares
+23.58K
Strike price
6.315
Held after
23.58K
Exercisable
—
11/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Warrant (right to buy) Direct | Common Stock23.58K shares | 11/25/2025 | P · Purchase | +23.58K | 6.315 | — | 23.58K |
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned15.00
Common Stock
IndirectShares owned230.00
Common Stock
IndirectShares owned230.00
Common Stock
IndirectShares owned230.00
Total
705.00 indirect705.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.00 | Indirect |
| Common Stock | 230.00 | Indirect |
| Common Stock | 230.00 | Indirect |
| Common Stock | 230.00 | Indirect |
| Total | 705.00 | 705.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported